REPOCEUTICALS

RepoCeuticals' strategy is to reposition, reroute, and recombine natural agents for new prophylactic and therapeutic uses for reducing the significant and severe side effects of radiotherapy and cytotoxic therapy in treatment of cancer, and for new therapeutic uses for relieving the devastating symptoms and chronic consequences of low anterior resection syndrome.

Also known as: RepoCeuticals A/S

Registration numbers: 36 49 44 33 (W)